Carlisle Cos. (CSL) Misses Q3 EPS by 5c, provides outlook
Tweet
Share
E-mailGet Alerts CSL Hot Sheet
Price: $378.53 +7.27%
EPS Growth %: +2.4%
Financial Fact:
Research and development expenses: 12.3M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +2.4%
Financial Fact:
Research and development expenses: 12.3M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Carlisle Cos. (NYSE: CSL) reported Q3 EPS of $5.78, $0.05 worse than the analyst estimate of $5.83. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.38 billion.
2024 Fourth Quarter Outlook
Revenues to increase LSD
CCM - up MSD
CWT - down LSD
Adjusted EBITDA margin ~ 25%
For earnings history and earnings-related data on Carlisle Cos. (CSL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q4 EPS by 4c
- Raymond James Starts MapLight Therapeutics (MPLT) at Strong Buy
- ARS Pharmaceuticals cuts 2026 expenses after no new neffy coverage gains
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
